Sorafenib Inhibits Imatinib-Resistant KIT and Platelet-Derived Growth Factor Receptor β Gatekeeper Mutants
Teresa Guida(Institute for Experimental Endocrinology and Oncology), Francesca Carlomagno(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy))
Cited by 73
Related Papers
BAY 43-9006 Inhibition of Oncogenic RET Mutants
|JNCI Journal of the National Cancer Institute|2006|471
The Extent of Linkage Disequilibrium in Four Populations with Distinct Demographic Histories
|The American Journal of Human Genetics|2000|182
Identification of tyrosine 806 as a molecular determinant of RET kinase sensitivity to ZD6474
|Endocrine Related Cancer|2008|40
Targeted activity of the small molecule kinase inhibitor Pz-1 towards RET and TRK kinases
|Scientific Reports|2021|17